Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RAPT
#1871
RAPT Therapeutics Inc
58.020
0
USD
+0.07%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.07%
Monthly Change
+0.38%
6 month change
+0.38%
Year Change
+0.38%
Previous Close
57.980
0
Open
58.020
0
Bid
58.020
0
Ask
58.023
0
Low
58.020
0
High
58.020
0
Volume
47
Markets
US Stock Market
Healthcare
RAPT
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
4.37 M
16.5 M
16.54 M
16.54 M
27.71 M
—
Valuation ratios
Enterprise value
—
—
—
90.42 M
676.73 M
—
Price to earnings ratio
—
—
—
-0.54
-2.21
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
1
5.29
—
Price to book ratio
—
—
—
0.11
0.46
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.17
0.22
0.09
0.1
0.11
0.52
Return on equity %
0.19
0.28
0.1
0.11
0.12
0.6
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.9
4.87
21.11
13.25
12.04
51.27
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
3.62
2.05
1.95
0.42
0.46
4.88
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
20.13
45.36
6.66
6.27
5.83
64.12
Net current asset value per share
21.1
46.17
6.8
6.41
5.97
65.36
Tangible book value per share
19.64
37.27
6.59
6.1
5.64
55.6
Working capital per share
18.97
36.68
6.48
5.93
5.48
54.57
Book value per share
19.64
37.27
6.59
6.1
5.64
55.6
News
GSK completes $2.2 billion acquisition of RAPT Therapeutics
RAPT Therapeutics stock hits 52-week high at $57.98
Rapt Therapeutics stock hits 52-week high at 57.87 USD
Rapt Therapeutics stock reaches 52-week high at $57.71
GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout
Rapt Therapeutics stock hits 52-week high at $57.62
GSK acquires Rapt Therapeutics stock for $2.2 billion as Leerink downgrades
GSK Digs In On Allergies With $2.2 Billion Rapt Therapeutics Buyout
RAPT Therapeutics: A Buy As GSK Acquisition Highlights Long-Acting IgE Candidate (RAPT)
Shopify, AeroVironment among market cap stock movers on Tuesday
GSK makes $2.2 billion swoop for RAPT Therapeutics’ food allergy drug
Intel and SanDisk among market cap stock movers on Tuesday